Vascular Insights, a manufacturer of peripheral vascular devices, has started a multi-center dose-finding study of its non-thermal vein ablation ClariVein system, designed to treat venous reflux diseases. The ClariVein system uses ...
Tags: peripheral vascular device, clinical trial, clinical technology
The US Food and Drug Administration (FDA) has cleared Carestream's new lesion management module, designed to help enhance both diagnostic confidence and radiologist productivity. The new tool, which is designed for use with the ...
Arch Biopartners has signed an agreement to buy a new diagnostic technology, which identifies irritable bowel syndrome (IBS). The technology helps clinicians to diagnose IBS that causes frequent abdominal discomfort, pain and ...
Tags: diagnostic technology, IBS, Arch Biopartners, clinical technology
RaySearch Laboratories has introduced a new version of RayStation treatment planning system, RayStation 3.0, for clinical use in the European Union, US, Japan and Australia. The RayStation 3.0 is designed to allow the users to perform ...
Tags: RaySearch, RayStation treatment planning system, clinical technology
Affymetrix has launched SensationPlus FFPE Amplification and 3' IVT Labeling Kit (SensationPlus FFPE Reagent Kit). SensationPlus FFPE Reagent Kit, which comprises RNA amplification and labeling modules, is designed to enable gene ...
Tags: FFPE Reagent Kit, 3'IVT Labeling Kit, clinical technology
Transgenomic has entered into a collaboration agreement to provide its next-generation genetic testing services to Medical College of Wisconsin (MCW). Under the agreement, Transgenomic will provide its Nuclear Mitome test, designed to ...
Tags: genetic testing service, clinica trial, clinical technology
Exactech, a developer of bone and joint restoration products, and Conmed have partnered to co-develop a series of medical education programs to advance standard of care for patients across the continuum of shoulder and knee repair. ...
Tags: medical education program, Exactech, clinical technology
Roche has announced the US launch of automated Elecsys HE4 assay, designed as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. The assay, which is approved for use on the Elecsys ...
Tags: epithelial ovarian cancer, clinical technology, clinical trial
Cartiva, a developer of orthopedic implants, has completed enrolling patients in its MOTION trial. The prospective, multi-center trial, which has enrolled 233 patients across Canada and the UK, is designed to assess the company's ...
Tags: Cartiva, clinical trial, clinical technology
QUANTEL Medical has entered into a collaboration agreement to license IRIDEX's proprietary noninvasive tissue-sparing laser delivery therapy, designed for treating sight-threatening diseases of the eye including complications associated ...
Genalyte, a provider of multiplex detection technologies, has unveiled Maverick ENA 4 and ENA 6 assay kits. The Maverick ENA 4 and ENA 6 assay kits, which are designed for use on the company's Maverick Detection system, simultaneously ...
Department of Veterans Affairs has granted approval to Breathe Technologies' Non-Invasive Open Ventilation (NIOV) system, designed to treat chronic obstructive pulmonary disease. FDA-cleared NIOV system, which will be added to the ...
Tags: Breathe NIOV System, chronic obstructive pulmonary disease
Navidea Biopharmaceuticals has entered into an agreement to license Alseres Pharmaceuticals' Iodine-123 radiolabeled imaging agent, [123I]-E-IACFT Injection (CFT). The patented small molecule radiopharmaceutical imaging agent, which ...
Ceretec has launched a nitric-oxide (NO) lung diffusion gas mixture, NO-Diff, for use in membrane diffusing capacity (DLNO) testing in pulmonary function laboratories in the US. The gas product, classified as Class 1 medical device by ...
Tags: medical device, lung diffusion gas mixture, clinical technology
Avinger has completed enrolling peripheral artery disease (PAD) patients in its CONNECT II clinical trial. The prospective, multi-center, non-randomized trial that evaluated 100 PAD patients with femoropopliteal CTO lesions was ...
Tags: clinical trial, peripheral artery disease, clinical technology, Avinger